(Q42186319)

18 October 2017

Total body weight loss of ≥ 10 % is associated with improved hepatic fibrosis in patients with nonalcoholic steatohepatitis (English)

1 reference

18 October 2017

0 references

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25354830%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Lisa M Glass

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25354830%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Rolland C Dickson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25354830%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Joseph C Anderson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25354830%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Arief A Suriawinata

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25354830%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Brian S Berk

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25354830%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

Arifa Toor

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25354830%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

language of work or name

1 reference

30 October 2014

1 reference

Digestive Diseases and Sciences

18 October 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25354830%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

60

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25354830%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25354830%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

1024-1030

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25354830%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s10620-014-3380-3

7 June 2020

exact match

0 references

cites work

Obesity and severe obesity forecasts through 2030.

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

Serum ferritin is an independent predictor of histologic severity and advanced fibrosis in patients with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

The relevance of liver histology to predicting clinically meaningful outcomes in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10620-014-3380-3

Resolution of nonalcoholic steatohepatits after gastric bypass surgery

21 January 2018

1 reference

12 December 2020

Effects of bariatric surgery on nonalcoholic fatty liver disease: preliminary findings after 2 years

1 reference

12 December 2020

Surgically-induced weight loss significantly improves nonalcoholic fatty liver disease and the metabolic syndrome

1 reference

12 December 2020

Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality

1 reference

12 December 2020

Pathophysiology of nonalcoholic steatohepatitis

1 reference

12 December 2020

Bariatric surgery for non-alcoholic steatohepatitis in obese patients

1 reference

12 December 2020

Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review.

1 reference

12 December 2020

10.1007/S10620-014-3380-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25354830%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference